PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
6.84%
Net income growth at 50-75% of BTE's 12.76%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
9.05%
D&A growth well above BTE's 4.97%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-697.22%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
1315.77%
Well above BTE's 381.69% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1315.77%
Growth well above BTE's 381.69%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
128.43%
Lower 'other non-cash' growth vs. BTE's 412.04%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-3.02%
Negative yoy CFO while BTE is 35.82%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-165.51%
Negative yoy CapEx while BTE is 14.49%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-59.93%
Both yoy lines negative, with BTE at -187.72%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-189.76%
Both yoy lines negative, with BTE at -26.80%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment growth of 100.00% while BTE is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
230.06%
Stock issuance far above BTE's 143.64%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
100.86%
Buyback growth of 100.86% while BTE is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.